Hemithyroidectomy versus total thyroidectomy in the intermediate-risk differentiated thyroid cancer: the Italian Societies of Endocrine Surgeons and Surgical Oncology …

C Dobrinja, N Samardzic, F Giudici, M Raffaelli… - Updates in Surgery, 2021 - Springer
The surgical treatment of the intermediate-risk DTC (1–4 cm) remains still controversial. We
analyzed the current practice in Italy regarding the surgical management of intermediate-risk …

[HTML][HTML] Incidence and predictors of synchronous bone metastasis in newly diagnosed differentiated thyroid cancer: A real-world population-based study

L Qi, W Zhang, X Ren, R Xu, C Liu, C Tu, Z Li - Frontiers in Surgery, 2022 - frontiersin.org
Background: Clinical and sociodemographic characteristics of differentiated thyroid cancer
(DTC) patients with synchronous bone metastasis (SBM) remain unclear. This real-world …

Controversy: For or against thyroid lobectomy in> 1 cm differentiated thyroid cancer?

F Menegaux, JC Lifante - Annales d'Endocrinologie, 2021 - Elsevier
In this controversy article, the respective advantages of lobectomy vs. total thyroidectomy in
differentiated thyroid cancers are argued. The authors conclude that lobectomy has the …

[PDF][PDF] A retrospective study of complications of total thyroidectomy; is it a safe approach for benign thyroid conditions

S Latif, HN Altaf, S Waseem, F Farooqui, OS Altaf… - …, 2019 - pdfs.semanticscholar.org
Objective: To assess frequency of complications of total thyroidectomy for benign thyroid
diseases. Methods: The retrospective descriptive study was conducted at Shifa College of …

The theranostic target prostate-specific membrane antigen is expressed in medullary thyroid cancer

L Lodewijk, SM Willems, KMA Dreijerink, B de Keizer… - Human pathology, 2018 - Elsevier
Medullary thyroid cancer (MTC) accounts for 4% of all thyroid cancers and originates from
the parafollicular C-cells. Prostate-specific membrane antigen (PSMA) is known for its …

Management of Low-risk Papillary Thyroid Cancer in a Patient with Familial Non-Medullary Thyroid Cancer

W Alobuia, E Kebebew - … in Thyroid Nodules and Differentiated Thyroid …, 2023 - Springer
The optimal surgical management of low-risk papillary thyroid cancer (PTC) has remained a
controversial topic for many decades. Recent guidelines propose that both thyroid …

Complications following completion thyroidectomy

Z Mehmood - Journal of Surgery Pakistan, 2019 - jsp.org.pk
Complications Following Completion Thyroidectomy Page 1 Complications Following Completion
Thyroidectomy INTRODUCTION: The most common endocrine tumour is thyroid carcinoma …

Thyroid malignancy: 5 years' experience

SA Razzak - Journal of Surgery Pakistan, 2019 - jsp.org.pk
Thyroid Malignancy: 5 years’ Experience Page 1 Thyroid Malignancy: 5 years’ Experience
INTRODUCTION: Thyroid carcinoma is the most common endocrine cancer accounting for …

[HTML][HTML] Malignancy in contralateral thyroid lobe

MN Baloch, SA Razzak, Z Mehmood… - Open Journal of …, 2019 - organscigroup.us
Objective: The aim of this study was to evaluate tumour in contralateral thyroid lobe who
underwent lobectomy and isthmusectomy for solitary thyroid nodule and proved malignant …

Additional Surgery for Occult Risk Factors After Lobectomy in Solitary Thyroid Nodules is Predicted by Cytopathology Classification and Tumor Size

A Flagg, L Rooper, S Sheth, M Shaear, P Santhanam… - Endocrine Practice, 2020 - Elsevier
Objective: Clinical practice for differentiated thyroid cancer is moving towards lobectomy
rather than total thyroidectomy in patients at low risk of recurrence. However, recurrence risk …